CO7071130A2 - Nuevas combinaciones para tratar la leucemia mieloide aguda o la leucemia mieloide cronica - Google Patents

Nuevas combinaciones para tratar la leucemia mieloide aguda o la leucemia mieloide cronica

Info

Publication number
CO7071130A2
CO7071130A2 CO14200660A CO14200660A CO7071130A2 CO 7071130 A2 CO7071130 A2 CO 7071130A2 CO 14200660 A CO14200660 A CO 14200660A CO 14200660 A CO14200660 A CO 14200660A CO 7071130 A2 CO7071130 A2 CO 7071130A2
Authority
CO
Colombia
Prior art keywords
myeloid leukemia
treat acute
new combinations
acute myeloid
chronic
Prior art date
Application number
CO14200660A
Other languages
English (en)
Inventor
Bernard Bourrie
Pierre Casellas
Sylvie Cosnier-Pucheu
Samir Jegham
Pierre Perreaut
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48040161&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO7071130(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of CO7071130A2 publication Critical patent/CO7071130A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

VER ANEXOS
CO14200660A 2012-03-14 2014-09-11 Nuevas combinaciones para tratar la leucemia mieloide aguda o la leucemia mieloide cronica CO7071130A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12305295.3A EP2638911A1 (en) 2012-03-14 2012-03-14 Novel combinations for treating acute myeloid leukaemia or chronic myeloid leukaemia

Publications (1)

Publication Number Publication Date
CO7071130A2 true CO7071130A2 (es) 2014-09-30

Family

ID=48040161

Family Applications (1)

Application Number Title Priority Date Filing Date
CO14200660A CO7071130A2 (es) 2012-03-14 2014-09-11 Nuevas combinaciones para tratar la leucemia mieloide aguda o la leucemia mieloide cronica

Country Status (19)

Country Link
US (1) US20150005253A1 (es)
EP (2) EP2638911A1 (es)
JP (1) JP2015509967A (es)
KR (1) KR20140138885A (es)
CN (1) CN104302298A (es)
AU (1) AU2013231227A1 (es)
CA (1) CA2866993A1 (es)
CL (1) CL2014002434A1 (es)
CO (1) CO7071130A2 (es)
CR (1) CR20140414A (es)
DO (1) DOP2014000206A (es)
EA (1) EA201491682A1 (es)
HK (1) HK1201202A1 (es)
MA (1) MA35938B1 (es)
MX (1) MX2014011054A (es)
PH (1) PH12014502020A1 (es)
SG (1) SG11201405566QA (es)
TN (1) TN2014000382A1 (es)
WO (1) WO2013135766A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109963571A (zh) * 2016-09-16 2019-07-02 拜奥-帕斯控股股份有限公司 含有脂质体反义寡核苷酸的组合疗法
CN108280321B (zh) * 2018-01-29 2021-09-17 沈阳药科大学 基于细胞代谢轮廓分析构建抗肿瘤候选化合物作用机制预测模型的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2887882B1 (fr) * 2005-07-01 2007-09-07 Sanofi Aventis Sa Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique
FR2910813B1 (fr) 2006-12-28 2009-02-06 Sanofi Aventis Sa Nouvelle utilisation therapeutique pour le traitement des leucemies

Also Published As

Publication number Publication date
DOP2014000206A (es) 2014-10-31
CA2866993A1 (en) 2013-09-19
AU2013231227A1 (en) 2014-10-02
JP2015509967A (ja) 2015-04-02
HK1201202A1 (en) 2015-08-28
CL2014002434A1 (es) 2014-12-19
EP2638911A1 (en) 2013-09-18
US20150005253A1 (en) 2015-01-01
MA35938B1 (fr) 2014-12-01
EA201491682A1 (ru) 2015-01-30
TN2014000382A1 (en) 2015-12-21
MX2014011054A (es) 2015-02-05
CN104302298A (zh) 2015-01-21
EP2825177A1 (en) 2015-01-21
CR20140414A (es) 2015-02-06
KR20140138885A (ko) 2014-12-04
WO2013135766A1 (en) 2013-09-19
SG11201405566QA (en) 2014-10-30
PH12014502020A1 (en) 2014-11-24

Similar Documents

Publication Publication Date Title
CL2015003085A1 (es) Novedosas moléculas de unión biespecífica con actividad antitumoral
CO7111289A2 (es) Compuestos inhibidores de metaloenzimas
UY34550A (es) Bencilpirazoles sustituidos
CO7020893A2 (es) Conjunto de desgaste
CO7091177A2 (es) Inhibidores de la beta-secretasa
CO7151512A2 (es) Inhibidores del nampt
CL2015002801A1 (es) Métodos para tratar la osteogénesis imperfecta.
HK1215790A1 (zh) 治療骨髓性白血病的方法
BR112014026634A2 (pt) direcionador
IN2013DE00266A (es)
CO7030954A2 (es) Procedimiento de produccion de lana mineral
IL244661A0 (en) Notch1-specific siRNA molecules
FR2985656B1 (fr) Oxymetre
CO7071130A2 (es) Nuevas combinaciones para tratar la leucemia mieloide aguda o la leucemia mieloide cronica
BR112016002321A2 (pt) saleiro com bocal de distribuição
CO7180191A2 (es) Métodos para separar hidrocarburos gaseosos
CO7151534A2 (es) Endoglucanasas con propiedades mejoradas
CO7320176A1 (es) Cubierta para frutas
BR112015021575A2 (pt) composição fungicida
GB201320656D0 (en) Pat table
ES1077970Y (es) Union para estructura/armazon de muebles
BR302013005636S1 (pt) Configuração aplicada em organizador de mesa
FR2996796B1 (fr) Table de decoupage
TN2011000420A1 (fr) طريقة علمية لمقاومة التصحر وتخصيب الصحراء
GT201400026S (es) Diseño de cubierta lateral para motocicleta